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The mature Gn glycoprotein of Crimean Congo hemorrhagic fever (CCHF) virus contains two predicted glycosylation sites (557N and 755N).
Of these, N-glycans are added only at 557N, as evidenced by abrogation of Gn-glycosylation by mutation of 557N but not 755N site. Mutational
block of Gn-glycosylation at 557N did not significantly affect Gn proteolytic processing but did result in mislocalization and retention of Gn and
other proteins synthesized from the virus M segment ORF (GP160, GP85, GP38 and Gc) in the endoplasmic reticulum. In contrast to Gn, similar
mutational analysis demonstrated that, while N-glycosylation occurs at the two predicted sites in Gc, abrogation of their glycosylation did not alter
localization of any of the CCHF virus glycoproteins. Studies of Gn expressed in the absence of Gc demonstrate that, while Gn processing and
localization are independent of Gc, all the CCHF virus glycoproteins appear dependent on N-glycosylation of Gn for correct folding, localization
and transport.
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Enveloped viruses usually contain one or more surface
glycoproteins and the majority of these are N-glycosylated. The
glycosylation machinery operating in the lumen of the
endoplasmic reticulum of the cells recognizes a specific
conformation of the glycosylation sequence Asn–X–Ser/Thr
(NXS/T) and attaches the glycans through the formation of an N-
glycosidic bond to the side chain of the asparagine residues
(Helenius and Aebi, 2004). N-linked glycosylation is known to
influence protein function in many ways, including protein
folding (Helenius and Aebi, 2001, 2004), chaperone association
(Molinari and Helenius, 2000); transport, cellular localization of
glycoproteins and virus infectivity (Hauri et al., 2000; Hannah et
al., 2005; Losman et al., 1999; Luftenegger et al., 2005; Shi and
Elliott, 2004; Shi et al., 2005). Among members of the Bunya-⁎ Corresponding author. Fax: +1 404 639 1118.
E-mail address: snichol@cdc.gov (S.T. Nichol).
0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2006.11.023viridae family, the functional significance of N-glycosylation of
the glycoproteins of Hantaan and Bunyamwera viruses has been
well documented (Shi and Elliott, 2004; Shi et al., 2005). In both
cases, mutation of the single N-glycosylation site utilized within
Gn resulted in misfolding and mislocalization, suggesting N-
glycosylation as a major determinant in the biogenesis of the
glycoproteins. Furthermore, a Gn-glycosylation mutant was
unable to rescue Bunyamwera virus in a reverse genetics system,
confirming that N-glycosylation of Gn was essential for virus
viability (Shi et al., 2005).
Crimean Congo hemorrhagic fever (CCHF) virus is a tick-
borne virus belonging to the genus Nairovirus of the family
Bunyaviridae. CCHF virus causes hemorrhagic manifestations
in humans with up to 30% case fatality. In contrast to viruses in
other genera of the family Bunyaviridae (such as Hantaan and
Bunyamwera viruses), the M segment of CCHF virus is appro-
ximately twice the size and encodes a polyprotein which under-
goes a complex proteolytic cascade to generate several precursor
and possible non-structural proteins (GP85, GP160, GP38,
mucin and NSm) in addition to the mature structural glycopro-
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and Garry, 2004; Sanchez et al., 2002, 2006; Vincent et al.,
2003). The proteolytic processing of precursors involves
multiple signalase cleavage events in the ER, SKI-1 and SKI-1
like protease cleavage events in the cis-Golgi network and
furin/PC cleavage in the trans-Golgi network (Sanchez et al.,
2002, 2006; Vincent et al., 2003). Given the increased proces-
sing complexity relative to Hantaan and Bunyamwera viruses,
we chose to examine the functional role of N-glycosylation of
the CCHF virus Gn and Gc in processing and localization and to
examine how this compared with results obtained with these
simpler members of the family Bunyaviridae. Results of our
mutagenesis and expression studies demonstrate that, despite
the increased complexity, similar results were found for CCHF
virus in that N-glycosylation of both Gn and Gc occurs, but only
Gn-glycosylation is important for the proper processing and
trafficking of CCHF virus glycoproteins.
Results
The only predicted N-glycosylation site (557N) in the Gn
extracellular domain is glycosylated
Using the existing CCHF virus glycoprotein processing
model as a starting point (Sanchez et al., 2006) andFig. 1. Glycosylation of Crimean Congo hemorrhagic fever virus Gn. (A) Diagrammat
denotes the mutation of asparagine to lysine and the numbers preceding N→K den
FL-755N→Kwere labeled for 30 min with 35S cysteine and chased for 3 h. Cells wer
virus–HMAF and proteins resolved in 3–8% NuPAGE gel. PreGn and PreGc re
unglycosylated, but cleaved Gn. The numbers in the left denote molecular weight mar
The immunoprecipitates were subjected to endoglycosidase digestion (+) or left untre
Gn and deglycosylated Gn, respectively. (D) SW13 cells expressing WT or mutants
against Gn epitopes and proteins resolved in 10% NuPAGE gel.N-glycosylation (NetNGly 1.0), transmembrane and protein
topology (TMHMM server v.2.0) prediction software, four
potential N-glycosylation sites within the mature Gn and Gc
glycoprotein sequences were identified for experimental
investigation. These included two potential glycosylation sites
(NXT/S motif) within the mature Gn of CCHF virus (Fig. 1A).
The motif at 557N is completely conserved among CCHF virus
strains for which sequences are known (32/32 strains, Deyde et
al., 2006), while the motif at 755N is conserved in 30/32 of the
virus strains. 557N is likely glycosylated as it is strongly
predicted to be located in the extracellular domain. In contrast,
755N is likely not glycosylated due to its cytoplasmic
orientation as per membrane topology predictions. These
NXT/S sites were individually mutated to investigate their
potential utilization and function (Fig. 1A). The intracellular
processing of mature Gn and protein mobility differences were
analyzed by expressing the glycoproteins using a recombinant
vaccinia virus expression system (Fuerst et al., 1986) and
comparing wild type (FL-WT) and mutant (FL-557N→K and
FL-755N→K) proteins (Fig. 1A). Radiolabeling and immuno-
precipitation of FL-WT-expressing cell lysates using a poly-
clonal hyperimmune mouse ascitic fluid (HMAF) against
CCHF virus proteins indicated the presence of four prominent
proteins with approximate molecular masses, 140 kDa, 85 kDa,
75 kDa and 37 kDa (Fig. 1B, lane 1). These proteins haveic representation of CCHF virus glycoproteins and the mutants examined. N→K
ote the amino acid positions. (B) SW13 cells expressing WT, FL-557N→K or
e then lysed and the clarified supernatants were immunoprecipitated using CCHF
fer to the precursors of Gn and Gc, respectively and ungly.Gn refers to the
ker locations in the gel. (C) Experiment was performed as described for panel B.
ated (−) before resolving in 3–8% NuPAGE gel. Gn and degly.Gn refer to mature
indicated on the top of the panel were immunoprecipitated using an antibody
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PreGn, PreGc, Gc and Gn proteins, respectively (Sanchez et al.,
2002). Abrogation of the 557N site (FL-557N→K, Fig. 1B,
lane 2) but not the 755N site (FL-755N→K, lane 3) resulted in
the faster mobility of the mature Gn. This mobility shift
confirms the identity of the protein bands as Gn and
demonstrates that N-glycosylation normally occurs at the
557N site but not the 755N site. The 557N alteration appeared
to have no effect on PreGn production or its proteolytic
processing to generate Gn, suggesting that these events occur
independent of the glycosylation at 557N. This is in contrast to
the FL-557N→K effect on PreGc to Gc conversion, in that
significant impairment of Gc processing is seen with the
mutant (compare PreGc to Gc in Fig. 1B, lanes 1 and 2).Fig. 2. Mutation in the N-glycosylation site of Gn results in mislocalization of C
immunoprecipitated using CCHF virus–HMAF, and the proteins were resolved in 3
media during chase periods. Note the dramatic absence of those proteins in cells expre
at the left side, permeabilized and dual stained with CCHF virus polyclonal antibody
and merged. a, b and c are patterns observed with FL-WT. d, e and f are patterns obse
the change in localization of the proteins in FL-557N→K compared to FL-WTor FL
anti-ERp72 antibodies. a, b, and c are FL-WT localization patterns. d, e and f are
colocalized with the ERmarker in contrast to FL-WT. (D) Analysis of the localization
a, FL-WT; b, FL-557N→K; and c, FL-755N→K.In order to more precisely identify the glycosylated and
unglycosylated Gn proteins, immunoprecipitated CCHF virus
FL-WT or mutant glycoproteins were subjected to endo-H
digestion. From the untreated FL-WT samples, mature Gn re-
solved as a 37 kDa protein and endo-H digestion resulted in Gn
with faster mobility (35 kDa), consistent with removal of glyco-
sidic modifications (Fig. 1C, top panel). However, in the case of
Gn from FL-557N→K, both untreated and endo-H treated
proteins showed no size shift and resolved at 35 kDa. These data
provide further evidence that 557N is glycosylated and the
mutation effectively abrogated the glycosylation. In contrast, the
pattern of endo-H sensitivity seen with FL-755N→K was very
similar to that of the Wt protein (Fig. 1C, bottom panel),
indicating that 755N is not an N-glycosylation site.CHF virus glycoproteins. (A) The supernatants of cells from Fig. 1B were
–8% NuPAGE gel. GP160, GP85 and GP38 are the three proteins found in the
ssing FL-557N→K. (B) BHK-21 cells were transfected with plasmids indicated
(Anti-CCHF) and β-COP. Images were captured with both labels independently
rved for FL-557N→K. g, h and i are patterns observed for FL-755N→K. Note
-755N→K. (C) Localization of FL-WTand FL-557N→K using anti-CCHF and
FL-557N→K localization patterns. Note that FL-557N→K is predominantly
of FL-WTand Gn-glycosylation mutants using Gc monoclonal antibody (13G5).
351B.R. Erickson et al. / Virology 361 (2007) 348–355Gn processing occurs independent of Gc
Our previous studies indicated that PreGn and PreGc are
generated from the full-length precursor in a co-translational
manner (Fig. 1A) (Sanchez et al., 2002; Vincent et al., 2003).
However, the potential role of Gc in regulating or modulating Gn
processing or N-glycosylation is unknown. To address this
question, we created plasmid 1040↓WTby PCR amplification of
the region of the M segment which encodes the amino acids
1–1040 followed by an introduced stop codon (using the reverse
primer) to prevent addition of plasmid backbone encoded protein
tags (Fig. 1A). In addition, the 557N→K mutation was
introduced in the background of 1040↓WT to produce the
expression plasmid 1040↓557N→K. Proteins expressed from
these and full-length constructs were analyzed by immunopre-
cipitation using an antipeptide antibody specific to Gn sequences
(Fig. 1D). In cells expressing Gn in the absence of Gc (i.e.
1040↓WT), mature glycosylated Gn (37 kDa) was found as seenFig. 3. N-glycans are added to Gc at aa 1054N and 1563N. (A) Diagrammatic repr
mutation of asparagine to serine or lysine and the numbers preceding denote the amin
or both mutations incorporated in the gene (FL-1054N→S/1054N→K) were labele
clarified supernatants were immunoprecipitated using CCHF virus–HMAF and prote
and double mutations. (C) Cells expressing WT-FL or FL-1054N→S/1054N→K
(11E7). Note the change in mobility of Gc in the double mutant. (D) BHK-21 cells w
stained with 13G5 (anti-Gc monoclonal) and β-COP. Images were captured with
FL-1054N→K. d, e and f are patterns observed for FL-1563N→K. g, h and i are patt
of the proteins was observed due to mutations.for FL-WT (Fig. 1D, compare lanes 1 and 4), indicating that Gn
processing and N-glycosylation were independent of Gc. These
results were further confirmed by showing that the mature but
unglycosylated Gn (35 kDa protein) was synthesized by both FL-
557N→K and 1040↓557N→K (lanes 2 and 5). The fact that the
Gn-antipeptide antibody reacts with the 37 kDa and 35 kDa
proteins further confirms the identity of glycosylated and
unglycosylated Gn, respectively. Taken together, these results
indicate that, in addition to Gn cleavage being independent of Gn-
glycosylation, Gc does not play a critical role in facilitating Gn
processing or N-glycosylation.
Mutation of 557N alters the localization of CCHF virus M
segment-encoded proteins
In order to examine if the mutation of the N-glycosylation
site has altered the protein transport properties, we analyzed the
cell supernatants for CCHF virus-specific glycoproteinsesentation of CCHF virus Gc mutants examined. N→S or N→K denotes the
o acid positions. (B) SW13 cells expressing WT, FL-1054N→S, FL-1054N→K
d for 30 min with 35S cysteine and chased for 3 h. Cells were then lysed and the
ins resolved in 3–8% NuPAGE gel. Note the mobility shift based on individual
were lysed and immunoprecipitated using a Gc-specific monoclonal antibody
ere transfected with plasmids indicated at the left side, permeabilized and dual
both labels independently and merged. a, b and c are patterns observed with
erns observed for FL 1054N→S/1054N→K. Note that no change in localization
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previously (Sanchez et al., 2006), three viral glycoproteins
(GP160, GP85 and GP38) were detected in the supernatants
from FL-WTand FL-755N→K expressing cells (Fig. 2A, lanes
1 and 3). Interestingly, although the intracellular levels of the
PreGn were similar (refer Fig. 1B), the proteins shed into the
supernatants of FL-557N→K expressing cells were dramati-
cally reduced (Fig. 2A, lane 2). This result suggested that abro-
gation of Gn-glycosylation at 557N had impaired the secretion
of M segment-encoded glycoproteins. To determine if block of
Gn-glycosylation also affected glycoprotein localization, gly-
coproteins generated from plasmid FL-WT and the Gn-glycosy-
lation mutant plasmids were examined by indirect immunoflu-
orescence assay performed using the CCHF virus polyclonal
antibody (Fig. 2B). FL-WT glycoproteins exhibited predomi-
nantly Golgi staining with a moderate amount of staining also
detected in the endoplasmic reticulum (ER) (Fig. 2B, a). Double
staining using β-COP (Golgi marker) antibody confirmed the
colocalization of CCHF virus glycoproteins with the Golgi
(panel B-b and c). These data are consistent with previous
reports describing the intracellular localization of CCHF virus
glycoproteins (Bertolotti-Ciarlet et al., 2005; Haferkamp et al.,
2005). A similar staining pattern was observed for the FL-
755N→K mutant (Figs. 2B, g, h and i) as would be expected
based on the above results indicating lack of glycosylation at this
site. In contrast, similar analysis with FL-557N→K indicated
that almost all the proteins were localized in reticular structures
of the ER with very little present in Golgi structures (Figs. 2B, d,
e and f). Confirmation of the ER localization of FL-557N→K
was obtained by colocalization experiments using antibodies
against CCHF virus and an ER protein (anti-ERp72). CCHF
virus polyclonal antibody stained the glycoproteins synthesized
from FL-WT predominantly in the Golgi and to a limited extent
in the ER and significant localization was not observed with the
ER marker (Figs. 2C, a–c). On the other hand, FL-557N→K
showed extensive ER staining and colocalization as evidenced
by CCHF virus polyclonal antibody and ER marker, respec-
tively (Figs. 2C, d–f). These data clearly indicated that
abrogation of glycosylation at 557N had resulted in the retention
and mislocalization of the glycoproteins predominantly in the
ER. In addition, the specific localization of Gc was examined by
using a Gc-specific monoclonal antibody (13G5, kindly
provided by Dr. Jonathan Smith, USAMRIID). Gc synthesized
from FL-WTor FL-755N→K stained both in the ER and Golgi
structures (Figs. 2D, a and c), while Gc synthesized from FL-
557N→K stained predominantly in the ER with no apparent
colocalization with Golgi marker (Fig. 2D, b). Collectively the
above data confirmed that N-linked glycosylation at 557N plays
an important role in the correct transport of CCHF virus
glycoproteins from the ER to subsequent cellular compartments.
N-linked glycosylation occurs at site 1054N and 1563N in Gc
but is not essential for correct protein processing or
localization
We next investigated the potential utilization and functional
role of N-glycosylation sites within Gc (75 kDa), the othermajor structural glycoprotein of CCHF virus. There are a total
of four NXS/T motifs in Gc, and all of them are conserved
among 32 characterized virus isolates (Deyde et al., 2006).
However, of these four NXS/T sites, only 1054N and 1563N
had a higher score as potential glycosylation sites, whereas
1194 is unlikely to be glycosylated due to the presence of a
proline residue at the X position (Shakin-Eshleman et al.,
1996; Kasturi et al., 1997) and 1345N had a negative score. In
order to examine the role of glycosylation in Gc processing
and transport, mutations were introduced in 1054N (FL-
1054N→S) and 1563N (FL-1563N→K) individually or in
combination (FL-1054N→S/1563N→K) and analyzed by
immunoprecipitation using CCHF virus–HMAF (Fig. 3A).
Our data indicated that both 1054N and 1563N are N-
glycosylated in the FL-WT protein as evidenced by a shift in
mobility of Gc in both mutants (Fig. 3B, lanes 1–4).
Consistent with glycosylation at the individual sites, mutations
at both 1054N and 1563N resulted in a protein resolving
approximately 5 kDa smaller than that observed from FL-WT
protein (Fig. 3B, lane 4). A similar Gc protein mobility shift
was observed in a separate immunoprecipitation experiment
utilizing a Gc-specific monoclonal antibody, thus confirming
the identity of the Gc protein bands (Fig. 3C). Although the
glycosylation was abrogated by mutation, Gc glycosylation
negative mutants were found to exhibit Golgi and ER staining
indistinguishable from that observed with FL-WT-expressing
cells (compare Fig. 3D with Fig. 2B). Together, these data
show that while Gc glycosylation does occur at the 1054N and
1563N sites, its abrogation did not affect the localization of
the glycoproteins.
Discussion
The synthesis of CCHF virus glycoproteins appears to
involve a complex cascade of proteolytic cleavage events to
generate the mature Gn and Gc glycoproteins and their
trafficking from the ER to the Golgi where virus assembly
takes place (Sanchez et al., 2002, 2006; Vincent et al., 2003;
Garry and Garry, 2004; Bertolotti-Ciarlet et al., 2005;
Haferkamp et al., 2005;). Two primary precursor proteins,
PreGn (140 kDa) and PreGc (85 kDa), are cleaved to generate
mature Gn and Gc, respectively (Sanchez et al., 2002). The
protease SKI-1 has been shown to cleave at an RRLL motif to
generate the Gn amino terminus (Vincent et al., 2003).
Similarly, the Gc amino terminus is preceded by an RKPL
motif which is probably cleaved by an SKI-1 like protease
(Vincent et al., 2003). SKI-1 protease, which is responsible for
generating Gn from PreGn, is localized in early Golgi and ER
structures and plays a key role in the proteolytic activation of
few prohormones (brain derived nucleotrophic factor, sterol
regulatory element-binding proteins, activating transcription
factor 6) (Pullikotil et al., 2004) and the glycoproteins of two
arenaviruses (Lassa and lymphocytic choriomeningitis viruses)
(Beyer et al., 2003). Experiments performed under BFA
treatment conditions indicate that SKI-1 cleavage of CCHF
virus glycoprotein occurs early in the ER or cis-Golgi structures
(Vincent et al., 2003), similar to results seen with Lassa virus
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protease further cleaves precursor proteins (at an RSKR motif)
in the trans-Golgi network (Sanchez et al., 2006). Glycosylation
can play a major role in viral glycoprotein folding and
trafficking and can profoundly influence virus tropism,
infectivity and antigenicity. For these reasons we chose to
examine the role of Gn and Gc N-glycosylation in the
processing and trafficking of these important proteins.
Our data demonstrated that one N-glycosylation site located
in the extracellular domain of Gn (557N) and two sites located
in the extracellular domain of Gc (1054N and 1563N) were
glycosylated. The motif representing these glycosylation sites is
conserved among all 32 CCHF virus M segments for which the
sequences are known (Deyde et al., 2006) strongly suggestive of
a functional role. Interestingly, mutational abrogation of N-
glycosylation at 557N did not prevent the cleavage of mature
Gn, but rather disrupted correct localization of Gn and the other
major structural glycoprotein Gc predominantly in the ER. In
contrast, mutational abrogation of Gc glycosylation did not
negatively affect Gc proteolytic processing or localization of
Gn, Gc or other virus glycoproteins. These findings are
reminiscent of those obtained for Bunyamwera (BUN) virus
glycoproteins, where it was found that the replacement of the
only glycosylation site in Gn (N60 to Q) did not abolish the
proteolytic processing of mature Gn, but instead generated a
misfolded Gn protein which resulted in both Gn and Gc being
retained in the ER (Shi et al., 2005). In addition, it was found
that infectious BUN virus could not be rescued by reverse
genetics using an M segment derived expression plasmid
producing Gn with the N60 to Q mutation. In contrast, using the
same approach, Gc mutations which abrogated Gc glycosyla-
tion did allow recovery of infectious BUN viruses (Shi et al.,
2005). The authors hypothesized that the larger Gc protein
depended on Gn for proper folding and heterodimerization. A
similar interpretation may apply to the CCHF virus glycoprotein
data presented here. We also observed that mutation of the only
N-glycosylation site at the extracellular domain of mature Gn
resulted in the retention of both Gn and Gc in the ER. Thus, N-
linked glycosylation of Gn, but not Gc, appears to play an
important role in the proper localization and transport of CCHF
and other family Bunyaviridae virus glycoproteins. In spite of
that similarity, CCHF virus appears to follow a very complex
pathway utilizing many proteases in the proteolytic cleavage of
its glycoprotein subunits.
A single mutation within CCHF virus mature Gn affecting
the localization of PreGn and PreGc derived glycoproteins
suggests that there is likely a Gn-glycosylation dependent
folding event which facilitates the transport of Gn, Gc and other
CCHF virus glycoproteins. Previous studies have indicated that
Gc expressed in the absence of Gn is localized in the ER, that
Gn has the signal for Golgi targeting, and Gn/Gc association
results in the localization of Gc in the Golgi (Bertolotti-Ciarlet
et al., 2005; Haferkamp et al., 2005). It follows then that the Gn
557N→K which results in abrogation of glycosylation and
mislocalization of Gn in the ER should result in the retention of
Gc and other associated proteins in the same compartment.
Interestingly, although the 557N→K mutation did not affectGn processing, the cleavage of Gc from PreGc appears to be
impaired as evidenced by the detection of less Gc and more
PreGc than seen with FL-WT (Fig. 1B, lane 2). As earlier
studies have shown that Gc cleave occurs early in the secretory
pathway (Vincent et al., 2003), it is unlikely that the reduction
in Gc processing seen with unglycosylated Gn is due to
retention of Gc in the ER. It is more plausible that the lack of
Gc interaction with unglycosylated Gn and its misfolding
results in the Gc cleavage site being less accessible to the
protease.
Given the apparent equivalent importance of the Gn-
glycosylation found in both CCHF and BUN viruses, it would
be predicted that abrogation of Gn-glycosylation might be
detrimental to the growth and infectivity of CCHF virus in a
manner similar to that seen with BUN virus (Shi et al., 2005).
Testing of this prediction will have to await successful
development of a reverse genetics system for CCHF virus.
In summary, this study demonstrates the N-glycosylation of a
conserved site in the CCHF virus Gn glycoprotein and
documents its apparent importance for correct glycoprotein
localization and transport. These data provide insight into the
complex pathway involved in the biosynthesis of CCHF virus
glycoproteins and have important implications for design of
recombinant vaccines and antiviral strategies.
Materials and methods
Cells, viruses, plasmids and antibodies
SW13 and BHK-21 cells were used in the present study.
SW13 cells were grown in DMEM supplemented with 10%
fetal bovine serum and antibiotics as previously described
(Sanchez et al., 2002). BHK-21 cells were grown in Glasgow
Minimum Essential Medium (G-MEM), with 10% fetal bovine
serum, penicillin–streptomycin, sodium pyruvate, tryptone
broth and L-glutamine added. Stocks were grown and titered
in SW13 cells in the biosafety level 4 laboratory of the Centers
for Disease Control and Prevention, Atlanta, GA using
IbAr10200 (from Hyalomma excavatum ticks from Sokoto,
Nigeria) as the seed stock. The M segment WT-ORF cloned into
pcDNA3.1 Directional-TOPO expression vector (Invitrogen)
was described previously (Sanchez et al., 2002). Protein
expression was performed using the recombinant vaccinia
virus (vvTF7-3) expression system developed by Fuerst et al.
(1986).
Polyclonal hyperimmune mouse ascitic fluid (HMAF)
developed against total CCHF virus IbAr10200 strain proteins
was kindly provided by Drs. T. Ksiazek and P. Rollin, CDC.
Gn-specific rabbit antipeptide antibody was generated under
contract (Research Genetics) and is referred to as Gn/540–551.
Gc-specific monoclonal antibody (MAb) 11E7 originally from
Jonathan Smith (formerly of the U.S. Army Medical Research
Institute for Infectious Diseases (USAMRIID), Fort Detrick,
MD) was kindly provided by Dr. Robert Doms; rabbit anti-β-
COP polyclonal antibody and rabbit anti-Erp72 were purchased
from ABR-Affinity BioReagents (Golden, CO) and Calbio-
chem (La Jolla, CA), respectively.
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with mutations in the N-glycosylation sites
CCHF virus strain IbAr10200 complete M segment wild
type (WT) ORF (Sanchez et al., 2002) was used as templates to
generate mutants. To introduce mutations at the predicted
glycosylation sites, we employed the QuikChange II XL Site-
Directed Mutagenesis kit (Stratagene) following the manufac-
turer's recommendations using the following primers: (1) for
FL-557N→K: forward primer: ATAACCATCTGCAAAGG-
CTCAACTATT and reverse primer: AATAGTTGAGCCT-
TTGCAGATGGTTAT; (2) for FL-755N→K: forward primer:
ATGCATGACCTCAAATGCAGTTACAAC and reverse pri-
mer: GTTGTAACTGCATTTGAGGTCATGCAT; (3) for
FL-1054N→S: forward primer: AAAAATCTGCTAAGTT-
CAACAAGTTTA and reverse primer: TAAACTTGTT-
GAACTTAGCAGATTTTT; for FL-1563N→K: forward
primer: ATCGGAAAGCAAAAAAGCACTTGCACG and re-
verse primer: CGTGCAAGTGCTTTTTTGCTTTCCGAT. The
presence of introduced changes in the gene was confirmed by
complete sequencing of the ORF. Due to the larger plasmid size
(more than 10 kb), we chose amino acid substitutions for N
which can be generated with minimal nucleotide alterations.
Transfection, metabolic labeling and
radioimmunoprecipitation of glycoproteins
Sub-confluent monolayers of SW13 or BHK-21 cells
(5×105) grown in 6 well plates were infected with recombinant
vaccinia virus vTF7-3 at an MOI of 5 for 1 h at 37 °C. During
virus adsorption, a mix containing plasmid DNA, Plus Reagent
(Invitrogen) and Lipofectamine Reagent (Invitrogen) was made
as recommended by the manufacturer. After removal of viral
inoculum, DNA complexes were added to cell monolayers and
incubated for 20 h. For experiments involving radioimmuno-
precipitation, cells were starved in cysteine-free medium for 1 h
followed by labeling with 100 μCi of [35S]cysteine (Perkin
Elmer Life Sciences) for 30 min. Label was then removed and
replaced with normal growth media containing cysteine and
cells chased for indicated times. At the end, cells were lysed and
immunoprecipitated as described before (Sanchez et al., 2002),
resolved on 3–8% NuPAGE precast gel systems (Invitrogen)
and analyzed by autoradiography.
Treatment of immunoprecipitated CCHF virus glycoproteins
with glycosidase enzymes
In order to investigate the nature of glycosidic modifications
on the CCHF virus glycoproteins, endo-H digestion of
immunoprecipitated proteins was performed at 37 °C overnight.
The digested proteins were resolved on NuPAGE gels under
reducing conditions and analyzed by autoradiography.
Indirect immunofluorescence assay
Cells grown on cover slips were infected with recombinant
vaccinia virus expressing bacteriophage T7 RNA polymerase atan MOI of 5 and transfected with the various constructs
following the same procedures described for immunoprecipita-
tion assays. At 20 h post-transfection cells were rinsed with PBS
and fixed with 3.6% paraformaldehyde for 10 min and
permeabilized with 0.5% Triton X-100 in PBS for 10 min.
After appropriate primary and secondary antibody treatments
for 30 min at room temperature, cells were thoroughly washed
and were mounted onto glass slides. Localization of glycopro-
teins was analyzed using a Zeiss Axioplan microscope and
images captured with a Nikon CoolPix 9500 digital camera.
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